Nick Noriea

Senior Chair/Manager

Nick Noriea is a research-trained Biosafety professional from the gulf coast. He holds a BS in Biology, a MS in Computer Science, and a PhD in Microbiology. Prior to entering biosafety, he was a postdoctoral fellow at the National Institutes of Health. Nick has served as biosafety officer in academia and reviewed and assessed hundreds of basic and clinical research sites for the Institutional Biosafety Committee. Nick serves as one of the IBC Chairs at Clinical Biosafety Services overseeing the administration of hundreds of Institutional Biosafety Committees. As part of these responsibilities, Nick provides leadership and support to these committees and coordinates committee findings and recommendations with their respective Institution. In his spare time, Nick functions as a basenji wrangler, aquarist, Murakami enthusiast, shrimp po-boy consumer, and explorer of ideas to integrate technology and biological safety.

Back to our Team

Get in touch with us to discuss IBC services for your clinical trials.

Mission Statement

Our mission and expertise at Clinical Biosafety Services is to provide accelerated, compliant review of gene transfer/gene therapy clinical trials to a convened review of a site-specific Institutional Biosafety Committee (IBC). We do this by understanding the challenges in the two client relationship of serving an institution and a sponsor.

Our focus is to accelerate the trial, and remove regulatory burden and uncertainty by having our highly trained experts provide friendly, knowledgeable support during the review process. We understand these therapeutics will change medicine, and our service is to bring the trial to enrollment fruition, quickly and compliantly.